[HTML] nih.gov

[HTML][HTML] Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma

CL Meaney, A Zingone, D Brown, Y Yu, L Cao… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Background Lung cancer is the leading cause of cancer-related mortality worldwide. Low-
dose CT (LDCT) imaging is now recommended to screen high-risk lung cancer individuals …
被引用次数：30 相关文章

[引用][C] Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma

CL Meaney, A Zingone, D Brown, Y Yu, L Cao… - Oncotarget, 2017 - cir.nii.ac.jp
Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I
adenocarcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma

CL Meaney, A Zingone, D Brown, Y Yu, L Cao… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Lung cancer is the leading cause of cancer-related mortality worldwide. Low-
dose CT (LDCT) imaging is now recommended to screen high-risk lung cancer individuals …
[PDF] semanticscholar.org

[PDF][PDF] Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma

CL Meaney, A Zingone, D Brown, Y Yu, L Cao… - pdfs.semanticscholar.org
Background: Lung cancer is the leading cause of cancer-related mortality worldwide. Low-
dose CT (LDCT) imaging is now recommended to screen high-risk lung cancer individuals …

Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.

CL Meaney, A Zingone, D Brown, Y Yu, L Cao… - Oncotarget, 2017 - europepmc.org
Background Lung cancer is the leading cause of cancer-related mortality worldwide. Low-
dose CT (LDCT) imaging is now recommended to screen high-risk lung cancer individuals …
[HTML] oncotarget.com

[HTML][HTML] Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma

CL Meaney, A Zingone, D Brown, Y Yu, L Cao… - Oncotarget, 2017 - oncotarget.com
Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I
adenocarcinoma | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial …

Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.

CL Meaney, A Zingone, D Brown, Y Yu, L Cao… - Oncotarget, 2017 - europepmc.org
Background Lung cancer is the leading cause of cancer-related mortality worldwide. Low-
dose CT (LDCT) imaging is now recommended to screen high-risk lung cancer individuals …

Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma

CL Meaney, A Zingone, D Brown, Y Yu, L Cao… - Oncotarget, 2017 - oncotarget.com
Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I
adenocarcinoma | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial …